Discontinuous residues of factor IX constitute a surface for binding the anti-factor IX monoclonal antibody A-5

By Chang Y.-J.   Wu H.-L.   Hsu Y.-C.   Hamaguchi N.   Shi G.-Y.   Shen M.-C.   Lin S.-W.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 293-299

Elsevier

Access to resources Recommend Favorite

Determination of Activated Factor IX in Factor IX Concentrates with a Chromogenic Substrate - Pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC

By Prasa D.   Sturzebecher J.  

Thrombosis Research, Vol. 92, Iss. 2, 1998-10 ,pp. : 99-102

Elsevier

Access to resources Recommend Favorite

Comparing the Antithrombotic Efficacy of a Humanized Anti-factor IX(a) Monoclonal Antibody (SB 249417) to the Low Molecular Weight Heparin Enoxaparin In a Rat Model of Arterial Thrombosis

By Toomey J.R.   Blackburn M.N.   Storer B.L.   Valocik R.E.   Koster P.F.   Feuerstein G.Z.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 73-79

Elsevier

Access to resources Recommend Favorite

Induction of Acquired Factor IX Inhibitors in Cynomolgus Monkey (Macaca Fascicularis): A New Primate Model of Hemophilia B

By Tomokiyo K.   Teshima K.   Nakatomi Y.   Watanabe T.   Mizuguchi J.   Nozaki C.   Nakagaki T.   Miyamoto S.   Funatsu A.   Iwanaga S.  

Thrombosis Research, Vol. 102, Iss. 4, 2001-05 ,pp. : 363-374

Elsevier

Access to resources Recommend Favorite

Structure-Function Relationships in Factor IX and Factor IXa

By Schmidt A.E.   Bajaj S.P.  

Trends in Cardiovascular Medicine, Vol. 13, Iss. 1, 2003-01 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite